Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Targeting CD24 as a novel immunotherapy for solid cancers
Yan Yang, Guangming Zhu, Li Yang, et al.
Cell Communication and Signaling (2023) Vol. 21, Iss. 1
Open Access | Times Cited: 22

Showing 22 citing articles:

Cancer stem cells: advances in knowledge and implications for cancer therapy
Xianjing Chu, Wentao Tian, Jiaoyang Ning, et al.
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 81
Glycosylation: mechanisms, biological functions and clinical implications
Mengyuan He, Xiangxiang Zhou, Xin Wang
Signal Transduction and Targeted Therapy (2024) Vol. 9, Iss. 1
Open Access | Times Cited: 33
The impaired response of nasal epithelial cells to microplastic stimulation in asthma and COPD
Magdalena Paplińska‐Goryca, Paulina Misiukiewicz‐Stępień, Maria Wróbel, et al.
Scientific Reports (2025) Vol. 15, Iss. 1
Open Access | Times Cited: 2
Engineering CAR‐T Therapeutics for Enhanced Solid Tumor Targeting
Danqing Zhu, Wonjoon Kim, Hyunjin Lee, et al.
Advanced Materials (2025)
Closed Access | Times Cited: 1
Antitumor Research Based on Drug Delivery Carriers: Reversing the Polarization of Tumor-Associated Macrophages
Xinyu Cao, Shen Wan, Bingyu Wu, et al.
Molecular Pharmaceutics (2025)
Closed Access | Times Cited: 1
Checkpoint CD24 function on tumor and immunotherapy
Shiming Huang, Xiaobo Zhang, Yingtian Wei, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
From mechanism to therapy: the journey of CD24 in cancer
Kai Zhao, Caifeng Wu, Xiangjun Li, et al.
Frontiers in Immunology (2024) Vol. 15
Open Access | Times Cited: 6
Future theranostic strategies: emerging ovarian cancer biomarkers to bridge the gap between diagnosis and treatment
Weranga Rajapaksha, Riya Khetan, I. R. Johnson, et al.
Frontiers in Drug Delivery (2024) Vol. 4
Open Access | Times Cited: 5
Exosomes multiplex profiling, a promising strategy for early diagnosis of laryngeal cancer
Marco Bocchetti, Amalia Luce, Clara Iannarone, et al.
Journal of Translational Medicine (2024) Vol. 22, Iss. 1
Open Access | Times Cited: 5
Dual-target magneto-immunoassay with bifunctional nanohybrids for breast cancer exosome detection
Izzati Haizan, Min Yu Choi, Dong Hyeok Park, et al.
Talanta (2025) Vol. 286, pp. 127532-127532
Closed Access
Single-cell transcriptomic analyses reveal heterogeneity and key subsets associated with survival and response to PD-1 blockade in cervical squamous cell carcinoma
Xia Li, Zhao Zhao, Yanmei Cheng, et al.
Cancer Cell International (2025) Vol. 25, Iss. 1
Open Access
Unraveling the triad of hypoxia, cancer cell stemness, and drug resistance
Tongxuan Shang, Ziqi Jia, J. Li, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access
Targeted release of a bispecific fusion protein SIRPα/Siglec-10 by oncolytic adenovirus reinvigorates tumor-associated macrophages to improve therapeutic outcomes in solid tumors
Yenan Zhang, Bohao He, Peng Zou, et al.
Journal for ImmunoTherapy of Cancer (2025) Vol. 13, Iss. 4, pp. e010767-e010767
Open Access
Stem Cells in Cancer: From Mechanisms to Therapeutic Strategies
Laurence Haddadin, Xueqin Sun
Cells (2025) Vol. 14, Iss. 7, pp. 538-538
Open Access
Identification of Specific Biomarkers for Anaplastic Thyroid Carcinoma Through Spatial Transcriptomic and Immunohistochemical Profiling
Faridul Haq, Andrey Bychkov, Özgür Mete, et al.
Endocrine Pathology (2025) Vol. 36, Iss. 1
Closed Access
Unravelling CD24‐Siglec‐10 pathway: Cancer immunotherapy from basic science to clinical studies
Rudradeep Hazra, Soumyadeep Chattopadhyay, Arijit Mallick, et al.
Immunology (2024) Vol. 173, Iss. 3, pp. 442-469
Closed Access | Times Cited: 2
CD24 promotes metastasis and chemoresistance by directly targeting Arf6-ERK pathway in esophageal squamous cell carcinoma
Hong Pan, Tao-Yang Xu, Jiaojiao Xu, et al.
Cancer Letters (2024) Vol. 594, pp. 216994-216994
Closed Access | Times Cited: 1
Network analysis to identify driver genes and combination drugs in brain cancer
Farinaz Roshani, Mobina Ahvar, Ali Ebrahimi
Scientific Reports (2024) Vol. 14, Iss. 1
Open Access | Times Cited: 1
Relationship between immune checkpoint proteins and neoadjuvant chemotherapy response in breast cancer
Umut Kina Kilicaslan, Başak Aru, Sibel Aydın Aksu, et al.
Surgical Oncology (2024) Vol. 52, pp. 102037-102037
Closed Access
CD24 regulates extracellular vesicle release via an aSMase/PI3K/mTORC2/ROCK/actin pathway in B lymphocytes
Hong-Dien Phan, Willow R.B. Squires, Kaitlyn E. Mayne, et al.
bioRxiv (Cold Spring Harbor Laboratory) (2024)
Open Access
ST8SIA6 Sialylates CD24 to Enhance Its Membrane Localization in BRCA
Jinxia He, Fengchao Zhang, Bai-Yang Wu, et al.
Cells (2024) Vol. 14, Iss. 1, pp. 9-9
Open Access
Engineering antibodies with cancer‐associated binding sites
Yulong Tian, Yun Pan, Yingchun Zhang, et al.
BMEMat (2024)
Open Access
Page 1

Scroll to top